Monoclonal antibodies against BAMBI and use for the treatment of inflammatory diseases
The invention relates to monoclonal antibodies, in particular against a peptide of the BAMBI protein, as well as the uses thereof and methods comprising same. Preferably, the antibodies are used for the treatment of autoimmune diseases.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
06.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to monoclonal antibodies, in particular against a peptide of the BAMBI protein, as well as the uses thereof and methods comprising same. Preferably, the antibodies are used for the treatment of autoimmune diseases. |
---|---|
Bibliography: | Application Number: US201615780800 |